$CME

Hyperliquid Submits Amicus Brief Supporting Industry Innovation In U.S. Futures Trading

Hyperliquid and the Healthy Perps Coalition (HPC) filed an amicus brief supporting the CFTC's approval of perpetual futures contracts. The brief argues CME Group's lawsuit lacks standing and stifles innovation. HPC claims the CFTC's approval expanded the market, benefiting all exchanges. If CME succeeds, future innovations may face legal challenges, potentially slowing market development.

Original reporting
Published Sep 9, 2026, 4:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 5:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hyperliquid Submits Amicus Brief Supporting Industry Innovation In U.S. Futures Trading — source image
Decision brief

The 30-second read

$CMENeutralLow
01

Why it matters

The amicus brief argues CME lacks standing and that the CFTC's actions expand market opportunities.

02

Market read

Legal outcome could influence the regulatory landscape for crypto futures and affect CME's litigation exposure.

03

What to watch

Potential pushback from traditional market participants resistant to crypto integration.

Relevance 7/10Novelty 7/10Timing: today

Background

CME filed a lawsuit against the CFTC after the regulator approved Bitcoin perpetual futures on a regulated exchange.

Company-level read

Ticker impact

$CMENeutralMedium confidence
Context

CME Group's lawsuit against the CFTC may be affected by the amicus brief filed by Hyperliquid and the Healthy Perps Coalition.

Expected impact

Modest upside if the brief leads to dismissal of CME's suit.

Evidence & confidence

The brief challenges CME's standing; if successful, it may lower legal expenses and improve market perception.

Market effects

May encourage other exchanges to pursue regulated crypto futures.

U.S. futures market could see increased innovation and competition.

Sets precedent for regulatory treatment of crypto derivatives worldwide.

Counterpoint

CME may still pursue other legal avenues, limiting the brief's effect.

Key entities

  • Hyperliquid

    Crypto trading platform supporting the amicus brief.

  • CME Group

    Issuer of the lawsuit against the CFTC.

  • CFTC

    U.S. Commodity Futures Trading Commission.

Related articles

$CMEMed

CME Group Launches CME Securities Clearing Inc

CME Group plans to launch CME Securities Clearing Inc. on December 7, 2026, pending regulatory approvals. The new clearing house will facilitate U.S. Treasury cash and repo transactions, helping market participants comply with SEC's central clearing mandate. It will support various execution and clearing options, aiming to optimize capital efficiencies and reduce margin requirements.

$CMELow

CME Group to Launch CME Securities Clearing on December 7 to Expand Clearing Capacity, Choice and Capital Efficiency in the U.S. Treasury Market

CME Group plans to launch CME Securities Clearing on December 7, 2026, pending regulatory approval. The new clearing house will offer capital-efficient clearing for U.S. Treasury cash and repo transactions, complying with SEC's central clearing mandate. It will support cross-margining, reducing margin requirements and improving liquidity. According to CME Group, this launch aims to provide market participants with more capacity and resilience amid U.S. debt reaching $40 trillion.

$CMELow

CME Group to launch CME Securities Clearing on December 7, 2026

CME Group plans to launch CME Securities Clearing on December 7, 2026, pending regulatory approval. The new clearing house will facilitate U.S. Treasury cash and repo transactions, offering capital-efficient options to comply with SEC's central clearing mandate. The service aims to reduce margin requirements and improve liquidity for eligible firms.

$CMELow

CME Group to launch Treasury clearing house on Dec. 7

CME Group plans to launch an SEC-registered clearing house for US Treasury transactions on Dec. 7, pending approval. The service will handle cash Treasury and repo transactions, offering margin offset across products. The SEC's mandate for central clearing of Treasuries takes effect by 2026-2027. CME aims to add capacity and capital efficiency alongside its FICC partnership.

$CMEMed

Hyperliquid policy group cites 2 flaws in CME lawsuit

The Hyperliquid Policy Center filed an amicus brief supporting the CFTC in its legal dispute with CME Group, arguing that CME lacks standing and its interests fall outside the Commodity Exchange Act's protections. CME sued over the CFTC's approval of Kalshi's perpetual futures contract, claiming it should be classified as a swap. The CFTC and HPC contend CME's arguments are flawed and that the exchange could list similar products if it chose to. The case could impact the U.S. perpetual futures m